Encompass Health Corporation

NYSE:EHC Stock Report

Market Cap: US$11.7b

Encompass Health Future Growth

Future criteria checks 2/6

Encompass Health is forecast to grow earnings and revenue by 6.8% and 7.6% per annum respectively. EPS is expected to grow by 3.4% per annum. Return on equity is forecast to be 21.6% in 3 years.

Key information

6.8%

Earnings growth rate

3.4%

EPS growth rate

Healthcare earnings growth14.3%
Revenue growth rate7.6%
Future return on equity21.6%
Analyst coverage

Good

Last updated28 Apr 2025

Recent future growth updates

Recent updates

Here's Why Encompass Health Corporation's (NYSE:EHC) CEO May Deserve A Raise

Apr 25
Here's Why Encompass Health Corporation's (NYSE:EHC) CEO May Deserve A Raise

We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt

Mar 19
We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt

What Does Encompass Health Corporation's (NYSE:EHC) Share Price Indicate?

Feb 13
What Does Encompass Health Corporation's (NYSE:EHC) Share Price Indicate?

Earnings Not Telling The Story For Encompass Health Corporation (NYSE:EHC)

Jan 29
Earnings Not Telling The Story For Encompass Health Corporation (NYSE:EHC)

Here's Why Encompass Health (NYSE:EHC) Has Caught The Eye Of Investors

Dec 10
Here's Why Encompass Health (NYSE:EHC) Has Caught The Eye Of Investors

Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings

Oct 21
Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings

Is Encompass Health (NYSE:EHC) Using Too Much Debt?

Oct 03
Is Encompass Health (NYSE:EHC) Using Too Much Debt?

Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 27
Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year
author-image

Expanding Healthcare Services And Decisive Partnerships Propel Revenue Growth And Shareholder Value

Aug 25 Expanding service demand through significant growth in neurological and stroke treatment areas suggests potential for future revenue increases.

Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17

Aug 10
Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17

These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well

Jun 27
These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well

Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?

Jun 09
Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?

Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price

May 23
Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price

Encompass Health Corporation: Solid Quarterly Report Makes For A Buy

Aug 14

Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel

Aug 07

Encompass Health declares $0.15 dividend

Feb 23

Encompass Health: Incremental Returns On Capital Key, Confirm Buy

Feb 17

Earnings and Revenue Growth Forecasts

NYSE:EHC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20276,853587N/AN/A4
12/31/20266,3915654251,08211
12/31/20255,8875125131,01711
3/31/20255,5134943861,053N/A
12/31/20245,3734563601,003N/A
9/30/20245,215432270925N/A
6/30/20245,071409215872N/A
3/31/20244,957387239862N/A
12/31/20234,801362268851N/A
9/30/20234,692357241822N/A
6/30/20234,57433697677N/A
3/31/20234,450280144715N/A
12/31/20224,349256122706N/A
9/30/20224,25423281657N/A
6/30/20224,175242216765N/A
3/31/20223,844253216776N/A
12/31/20214,015298170716N/A
9/30/20214,187316381872N/A
6/30/20214,350318408868N/A
3/31/20214,693304410834N/A
12/31/20203,566193300705N/A
9/30/20204,614265244641N/A
6/30/20204,602285169582N/A
3/31/20204,66334289505N/A
12/31/20194,605358231635N/A
9/30/20194,517317238598N/A
6/30/20194,423308362682N/A
3/31/20194,355309417706N/A
12/31/20184,277290N/A762N/A
9/30/20184,190339N/A735N/A
6/30/20184,104316N/A712N/A
3/31/20184,003288N/A694N/A
12/31/20173,914271N/A658N/A
9/30/20173,841260N/A642N/A
6/30/20173,771256N/A645N/A
3/31/20173,710256N/A646N/A
12/31/20163,643247N/A640N/A
9/30/20163,576228N/A616N/A
6/30/20163,432217N/A602N/A
3/31/20163,280198N/A552N/A
12/31/20153,116181N/A502N/A
9/30/20152,857173N/A438N/A
6/30/20152,678172N/A415N/A
3/31/20152,520204N/A440N/A
12/31/20142,374208N/A445N/A
9/30/20142,336144N/A476N/A
6/30/20142,303148N/A479N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EHC's forecast earnings growth (6.8% per year) is above the savings rate (2.8%).

Earnings vs Market: EHC's earnings (6.8% per year) are forecast to grow slower than the US market (14.2% per year).

High Growth Earnings: EHC's earnings are forecast to grow, but not significantly.

Revenue vs Market: EHC's revenue (7.6% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: EHC's revenue (7.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: EHC's Return on Equity is forecast to be high in 3 years time (21.6%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/30 22:05
End of Day Share Price 2025/04/30 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Encompass Health Corporation is covered by 34 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null RESEARCH DEPARTMENTAvondale Partners
Matthew GillmorBaird
Ishan MajumdarBaptista Research